Evaluation Measures in Tropical Spastic Paraparesis
Literature Review
DOI:
https://doi.org/10.34024/rnc.2010.v18.8435Keywords:
Paraparesis Tropical Spastic, Human T-lymphotropic virus 1, HTLV-1Abstract
Introduction. The HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) is caused by the human T retrovirus and one of its major manifestations is the progressive spastic paraparesis. Objective. This study aims a literature review about the use of functional scales to evaluate subjects of HAM/TSP to give a guideline to the physical therapists who work in the rehabilitation of these patients. Method. In this literature review a search was made in the database of Bireme, Scielo and PubMed to identify evaluation profiles, measurements and indicators used with patients of neurological conditions. Discussion. Different evaluations instruments have been proposed to follow up subjects with neurological dysfunction along the course of their life, although recommendations for the use of certain instruments are not frequently discussed in the literature, especially with patients of HAM/TSP. Conclusion. The literature does not present uniformity in methods and proceeds of research. The FIM scale seems to be the most adequate instrument to evaluate the patients with HAM/TSP, since it is able measure the functional changes in the patients along the course of the disease.
Metrics
Downloads
References
Osame M. Pathological mechanism of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neuro Virol 2002;8:350-64.
Souza LA, Lopes IGL, Maia EL, Azevedo VN, Machado LF, Ishak MO, et al. Molecular characterization of HTLV-1 among patients with tropical paraparesis/HTLV-1 associated myelopathy in Belem, Para. Rev Bras Med Trop 2006;39:504-6.
Figueroa EN, Remondegui C, Valdez M, Pintado A. Paraparesia espástica tropical na província de Jujuy. Cuad Fac Humanid Cienc Soc 2004;22:273-86.
Proietti ABF, Ribas JGR, Soares BCC. Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil. Rev Soc Bras Med Trop 2002;35:499-508.
Orsini M, Lannes P, Machado D, Miana LC, Silva JG, Bastos VHV. Paraparesia Espástica Tropical: Mielopatia Associada ao HTLV - 1: Posíveis Estratégias cinesioterapêuticas para melhora dos padrões de marcha em portadores sintomáticos. Rev Neurocienc 2006;14:153-60.
Franzoi AC, Araújo AQC. Disability profile of patients with HTLV-1 associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM). Spinal Cord 2005;43:236-40.
Castro-Costa CM, Salgueiro MR, Calrton H, Vale OC, De Arruda AM. Tropical spastic paraparesis in the Northeastern Brazil. Arq Neuropsiquiatr 1989;47:134-8.
Castro LHM, Chaves CJ, Callegaro D, Nóbrega JP, Scaff M. HTLV1 associated myelopathy in the Northeastern Brazil. Arq Neuropsiquiatr 1989;47:501-2.
Catalan-Soares BC, Proietti FA, Carneiro-Proietti ABF. Os vírus linfotrópicos de células T humanas (HTLV-I) na última década (1990-2000): aspectos epidemiológicos. Rev Bras Epidemiol 2001;4:81-94.
Caneda MA, Fernande JG, Almeida AG, Mugnol FE. Reliability of neurological asessment scales in patients with stroke. Arq Neuropsiquiatr 2006;64:690-7.
Gosman-Hedström G, Svensson E. Parallel reliability of the Functional Independence Measure and the Barthel Index. Dis Rehab 2000;22:702-15.
Putten JJMF, Hobart JC, Freeman JA, Thompson AJ. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry 1999;66:480-4.
Arbizu-Urdiain T, Martinez-Yélamos A, Casado-Ruiz V. Escalas de deterioro, discapacidad y minusvalía em la esclerose múltiple. Neurol 2002;35:1081-93.
Felipe E, Mendes FM, Moreira MA, Tilbery CP. Análise comparativa entre duas escalas de avaliação clínica na esclerose múltipla. Arq Neuropsiquiatr 2000;58:300-3.
Claesson L, Svensson E. Measures of order consistency between paired ordinal data: application to the functional independence measure and Sunnaas index of ADL. J Rehab Med 2001;33:137-44.
Dodds TA, Matrin DP, Stolov WC, Deyo RA. A validation of the Functional Independence Measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil 1993;74:531-6.
Haley SM, Coster WJ, Blinda-Sundberg K. Measuring physical disablement: the contextual challenge. Phys Ther 1994;74:443-51.
Mendes FM, Balsimelli S, Stangehaus G, Tilbery PT. Validação de escala de determinação funcional da qualidade de vida na esclerose múltipla para a língua portuguesa. Arq Neuropsiquiatr 2004;62:108-13.
Stineman MG, Shea JA, Jette A, Tassoni CJ, Ottenbacher KJ, Fiedler R, et al. The functional independence measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories. Arch Phys Med Rehabil 1996;77:1101-8.
Bustamante SEZ, Bottino CMC, Lopes MA, Azevedo D, Hototian SR, Litvoc J, et al. Instrumentos combinados na avaliação de demência em idosos: resultados preliminares. Arq Neuropsiquiatr 2003;61:601-6.
Alarcón-Avilés T, Alarcón-Guzmán T, Roman CG. Tratamiento de la paraparesia espástica tropical con pentoxifilina: estudio piloto. Rev Ecuat Neurol 2002;1:1-2.
Alarcón-Gusmán T, Alarcón-Avilés T. Infección neurológica por HTLVI. Rev Ecuat Neurol 2001;10:12-9.
Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Med J 1965;14:56-61.
Loewen SC, Anderson BA. Reliability of the Modified Motor Assessment Scale and the Barthel Index. Phys Ther 1988;68:1077-81
Creel GL, Light KE, Thigpen MT. Concurrent and construct validity of scores on the timed movement battery. Phys Ther 1986;66:1233-8.
Kurtzke JF. A new scale for evaluating of disability in multiple sclerosis. Neurol 1955;5:580-3.
Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol 2000;57:1319-24.
Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol 1999;39:143-50.
Castro M, Caiuby AV, Draibe AS, Canziani ME. Qualidade de vida de pacientes com insuficiência renal crônica em hemodiálise avaliada através do instrumento genérico SF-36. Rev Assoc Med Bras 2003;49:245-9.
Downloads
Published
How to Cite
Issue
Section
##plugins.generic.dates.published## 2010-12-31
Português
English
Español
